January 30, 2006 - Seattle - VizX Labs today announced that the National Human Genome Research Institute (NHGRI) has purchased a fifteen-seat site license of the GeneSifter Core Edition online microarray data analysis system, for use in the NHGRI Computational Genomics Unit.

The agreement provides NHGRI with a powerful, award-winning microarray research tool in an intuitive system accessible online, which has been well received by the institute's researchers.

"GeneSifter isn't just a piece of software for the NHGRI, it's a solution." said VizX Vice President of Sales David Audley. "Working directly with the Deputy Scientific Director and his staff, we have rolled out a program that supports the bench researcher with scientific support and on-going product training so that they can move from microarray data to biological discovery. We believe this will be a model, not just for the NHGRI, but for major research institutions worldwide."

"From the Human Genome Project to their ongoing research into the genetics of cancer and other major diseases, the NHGRI has been at the center of some of the most exciting biological advances of our time," said VizX CEO Tom Ranken, "and we are very pleased that GeneSifter is now being so widely used there."

About GeneSifter br>GeneSifter software helps researchers derive biological understanding from gene expression patterns in microarray data. The web-based system was recently honored with the Frost & Sullivan "Best Practices Award for Product Innovation" in the Bioinformatics in Drug Discovery category, and recently received the distinction of "GeneChip-compatible™" from microarray leader Affymetrix. Customer comments are available online at www.genesifter.net/web/labtestimonials.html. Downloadable graphics, including screenshots of the GeneSifter Lab Edition and the new GeneSifter Core Edition, may be viewed online at www.vizxlabs.com/downloadable_images.html.

About VizX Labs
VizX Labs' GeneSifter software helps life scientists Understand the Biology™ revealed through data from microarray experiments. Featured in Wired News and Nature Methods, selected as a Northwest Venture All-Star company and named by Bio-IT World as one of six "bioinformatics youngbloods" remaking that field, VizX was listed by Washington CEO as one of the state's top 25 biotechnology and biomedical companies. To view the VizX Labs newsroom, please visit www.vizxlabs.com/newsroom.html.